Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 May;2(3):255–262. doi: 10.1128/cdli.2.3.255-262.1995

The molecular genetics of hematologic malignancies.

A Bagg 1
PMCID: PMC170141  PMID: 7664167

Full Text

The Full Text of this article is available as a PDF (201.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahuja H. G., Jat P. S., Foti A., Bar-Eli M., Cline M. J. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood. 1991 Dec 15;78(12):3259–3268. [PubMed] [Google Scholar]
  2. Allen R. C., Zoghbi H. Y., Moseley A. B., Rosenblatt H. M., Belmont J. W. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet. 1992 Dec;51(6):1229–1239. [PMC free article] [PubMed] [Google Scholar]
  3. Anastasi J. Fluorescence in situ hybridization in leukemia. Applications in diagnosis, subclassification, and monitoring the response to therapy. Ann N Y Acad Sci. 1993 Mar 20;677:214–224. doi: 10.1111/j.1749-6632.1993.tb38779.x. [DOI] [PubMed] [Google Scholar]
  4. Ayer D. E., Kretzner L., Eisenman R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 1993 Jan 29;72(2):211–222. doi: 10.1016/0092-8674(93)90661-9. [DOI] [PubMed] [Google Scholar]
  5. Barinaga M. Cell suicide: by ICE, not fire. Science. 1994 Feb 11;263(5148):754–756. doi: 10.1126/science.8303290. [DOI] [PubMed] [Google Scholar]
  6. Bedi A., Zehnbauer B. A., Barber J. P., Sharkis S. J., Jones R. J. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood. 1994 Apr 15;83(8):2038–2044. [PubMed] [Google Scholar]
  7. Bernasconi P., Alessandrino E. P., Boni M., Bonfichi M., Morra E., Lazzarino M., Campagnoli C., Astori C. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival. Am J Hematol. 1994 Aug;46(4):270–277. doi: 10.1002/ajh.2830460404. [DOI] [PubMed] [Google Scholar]
  8. Biondi A., Rambaldi A., Alcalay M., Pandolfi P. P., Lo Coco F., Diverio D., Rossi V., Mencarelli A., Longo L., Zangrilli D. RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood. 1991 Apr 1;77(7):1418–1422. [PubMed] [Google Scholar]
  9. Bird J. M., Russell N. H., Samson D. Minimal residual disease after bone marrow transplantation for multiple myeloma: evidence for cure in long-term survivors. Bone Marrow Transplant. 1993 Dec;12(6):651–654. [PubMed] [Google Scholar]
  10. Bird J., Galili N., Link M., Stites D., Sklar J. Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med. 1988 Jul 1;168(1):229–245. doi: 10.1084/jem.168.1.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Borowitz M. J., Hunger S. P., Carroll A. J., Shuster J. J., Pullen D. J., Steuber C. P., Cleary M. L. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood. 1993 Aug 15;82(4):1086–1091. [PubMed] [Google Scholar]
  12. Campos L., Rouault J. P., Sabido O., Oriol P., Roubi N., Vasselon C., Archimbaud E., Magaud J. P., Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 1993 Jun 1;81(11):3091–3096. [PubMed] [Google Scholar]
  13. Coghlan D. W., Morley A. A., Matthews J. P., Bishop J. F. The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia. Leukemia. 1994 Oct;8(10):1682–1687. [PubMed] [Google Scholar]
  14. Dedera D. A., Waller E. K., LeBrun D. P., Sen-Majumdar A., Stevens M. E., Barsh G. S., Cleary M. L. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 1993 Sep 10;74(5):833–843. doi: 10.1016/0092-8674(93)90463-z. [DOI] [PubMed] [Google Scholar]
  15. Fey M. F., Peter H. J., Hinds H. L., Zimmermann A., Liechti-Gallati S., Gerber H., Studer H., Tobler A. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe. J Clin Invest. 1992 May;89(5):1438–1444. doi: 10.1172/JCI115733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gribben J. G. Attainment of molecular remission: a worthwhile goal? J Clin Oncol. 1994 Aug;12(8):1532–1534. doi: 10.1200/JCO.1994.12.8.1532. [DOI] [PubMed] [Google Scholar]
  17. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F., Pelicci P. G. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994 Jan 1;83(1):10–25. [PubMed] [Google Scholar]
  18. Gsur A., Zöchbauer S., Götzl M., Kyrle P. A., Lechner K., Pirker R. MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update. Leuk Lymphoma. 1993 Dec;12(1-2):91–94. doi: 10.3109/10428199309059575. [DOI] [PubMed] [Google Scholar]
  19. Harris C. C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 1993 Oct 28;329(18):1318–1327. doi: 10.1056/NEJM199310283291807. [DOI] [PubMed] [Google Scholar]
  20. Hebert J., Cayuela J. M., Berkeley J., Sigaux F. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood. 1994 Dec 15;84(12):4038–4044. [PubMed] [Google Scholar]
  21. Heim S., Mitelman F. Cytogenetic analysis in the diagnosis of acute leukemia. Cancer. 1992 Sep 15;70(6 Suppl):1701–1709. doi: 10.1002/1097-0142(19920915)70:4+<1701::aid-cncr2820701609>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  22. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 1991 Jun 28;65(7):1107–1115. doi: 10.1016/0092-8674(91)90007-l. [DOI] [PubMed] [Google Scholar]
  23. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993 Oct 22;75(2):241–251. doi: 10.1016/0092-8674(93)80066-n. [DOI] [PubMed] [Google Scholar]
  24. Houldsworth J., Chaganti R. S. Comparative genomic hybridization: an overview. Am J Pathol. 1994 Dec;145(6):1253–1260. [PMC free article] [PubMed] [Google Scholar]
  25. Hunger S. P., Galili N., Carroll A. J., Crist W. M., Link M. P., Cleary M. L. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood. 1991 Feb 15;77(4):687–693. [PubMed] [Google Scholar]
  26. Imamura J., Miyoshi I., Koeffler H. P. p53 in hematologic malignancies. Blood. 1994 Oct 15;84(8):2412–2421. [PubMed] [Google Scholar]
  27. Inghirami G., Macri L., Rosati S., Zhu B. Y., Yee H. T., Knowles D. M. The Reed-Sternberg cells of Hodgkin disease are clonal. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9842–9846. doi: 10.1073/pnas.91.21.9842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Inoue K., Sugiyama H., Ogawa H., Nakagawa M., Yamagami T., Miwa H., Kita K., Hiraoka A., Masaoka T., Nasu K. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 1994 Nov 1;84(9):3071–3079. [PubMed] [Google Scholar]
  29. Jain V. K., Judde J. G., Max E. E., Magrath I. T. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation. J Immunol. 1993 Jun 15;150(12):5418–5428. [PubMed] [Google Scholar]
  30. Kawasaki E. S., Clark S. S., Coyne M. Y., Smith S. D., Champlin R., Witte O. N., McCormick F. P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5698–5702. doi: 10.1073/pnas.85.15.5698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell. 1994 Jun 17;77(6):791–793. doi: 10.1016/0092-8674(94)90125-2. [DOI] [PubMed] [Google Scholar]
  32. Korsmeyer S. J., Greene W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4522–4526. doi: 10.1073/pnas.80.14.4522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Korsmeyer S. J., Hieter P. A., Ravetch J. V., Poplack D. G., Waldmann T. A., Leder P. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7096–7100. doi: 10.1073/pnas.78.11.7096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kuss B. J., Deeley R. G., Cole S. P., Willman C. L., Kopecky K. J., Wolman S. R., Eyre H. J., Lane S. A., Nancarrow J. K., Whitmore S. A. Deletion of gene for multidrug resistance in acute myeloid leukaemia with inversion in chromosome 16: prognostic implications. Lancet. 1994 Jun 18;343(8912):1531–1534. doi: 10.1016/s0140-6736(94)92938-6. [DOI] [PubMed] [Google Scholar]
  35. Küppers R., Rajewsky K., Zhao M., Simons G., Laumann R., Fischer R., Hansmann M. L. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A. 1994 Nov 8;91(23):10962–10966. doi: 10.1073/pnas.91.23.10962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Levine A. M. AIDS-related malignancies: the emerging epidemic. J Natl Cancer Inst. 1993 Sep 1;85(17):1382–1397. doi: 10.1093/jnci/85.17.1382. [DOI] [PubMed] [Google Scholar]
  37. Levy R., Levy S., Cleary M. L., Carroll W., Kon S., Bird J., Sklar J. Somatic mutation in human B-cell tumors. Immunol Rev. 1987 Apr;96:43–58. doi: 10.1111/j.1600-065x.1987.tb00508.x. [DOI] [PubMed] [Google Scholar]
  38. Limpens J., de Jong D., van Krieken J. H., Price C. G., Young B. D., van Ommen G. J., Kluin P. M. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene. 1991 Dec;6(12):2271–2276. [PubMed] [Google Scholar]
  39. Lion T., Henn T., Gaiger A., Kalhs P., Gadner H. Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia. Lancet. 1993 Jan 30;341(8840):275–276. doi: 10.1016/0140-6736(93)92619-5. [DOI] [PubMed] [Google Scholar]
  40. Liu Y., Hernandez A. M., Shibata D., Cortopassi G. A. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8910–8914. doi: 10.1073/pnas.91.19.8910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Lo Coco F., Diverio D., Pandolfi P. P., Biondi A., Rossi V., Avvisati G., Rambaldi A., Arcese W., Petti M. C., Meloni G. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet. 1992 Dec 12;340(8833):1437–1438. doi: 10.1016/0140-6736(92)92625-p. [DOI] [PubMed] [Google Scholar]
  42. Lo Coco F., Gaidano G., Louie D. C., Offit K., Chaganti R. S., Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood. 1993 Oct 15;82(8):2289–2295. [PubMed] [Google Scholar]
  43. Loughran T. P., Jr Clonal diseases of large granular lymphocytes. Blood. 1993 Jul 1;82(1):1–14. [PubMed] [Google Scholar]
  44. Lovec H., Grzeschiczek A., Kowalski M. B., Möröy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994 Aug 1;13(15):3487–3495. doi: 10.1002/j.1460-2075.1994.tb06655.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lukas J., Jadayel D., Bartkova J., Nacheva E., Dyer M. J., Strauss M., Bartek J. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. Oncogene. 1994 Aug;9(8):2159–2167. [PubMed] [Google Scholar]
  46. Magrath I. T. African Burkitt's lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):222–246. [PubMed] [Google Scholar]
  47. Marx J. How cells cycle toward cancer. Science. 1994 Jan 21;263(5145):319–321. doi: 10.1126/science.8278804. [DOI] [PubMed] [Google Scholar]
  48. Miller W. H., Jr, Kakizuka A., Frankel S. R., Warrell R. P., Jr, DeBlasio A., Levine K., Evans R. M., Dmitrovsky E. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2694–2698. doi: 10.1073/pnas.89.7.2694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Mills K. I., Benn P., Birnie G. D. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood. 1991 Sep 1;78(5):1155–1161. [PubMed] [Google Scholar]
  50. Miyamura K., Barrett A. J., Kodera Y., Saito H. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results. Bone Marrow Transplant. 1994 Aug;14(2):201–209. [PubMed] [Google Scholar]
  51. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Liebermann D. A., Hoffman B., Reed J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 1994 Jun;9(6):1799–1805. [PubMed] [Google Scholar]
  52. Morgan G. J., Wiedemann L. M. The clinical application of molecular techniques in Philadelphia-positive leukaemia. Br J Haematol. 1992 Jan;80(1):1–5. doi: 10.1111/j.1365-2141.1992.tb06392.x. [DOI] [PubMed] [Google Scholar]
  53. Nakai H., Misawa S., Taniwaki M., Horiike S., Takashima T., Seriu T., Nakagawa H., Fujii H., Shimazaki C., Maruo N. Prognostic significance of loss of a chromosome 17p and p53 gene mutations in blast crisis of chronic myelogenous leukaemia. Br J Haematol. 1994 Jun;87(2):425–427. doi: 10.1111/j.1365-2141.1994.tb04938.x. [DOI] [PubMed] [Google Scholar]
  54. Nizet Y., Van Daele S., Lewalle P., Vaerman J. L., Philippe M., Vermylen C., Cornu G., Ferrant A., Michaux J. L., Martiat P. Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood. 1993 Sep 1;82(5):1618–1625. [PubMed] [Google Scholar]
  55. Nucifora G., Larson R. A., Rowley J. D. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood. 1993 Aug 1;82(3):712–715. [PubMed] [Google Scholar]
  56. Offit K., Lo Coco F., Louie D. C., Parsa N. Z., Leung D., Portlock C., Ye B. H., Lista F., Filippa D. A., Rosenbaum A. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med. 1994 Jul 14;331(2):74–80. doi: 10.1056/NEJM199407143310202. [DOI] [PubMed] [Google Scholar]
  57. Ohyashiki J. H., Ohyashiki K., Fujimura T., Kawakubo K., Shimamoto T., Iwabuchi A., Toyama K. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res. 1994 Jul 1;54(13):3557–3560. [PubMed] [Google Scholar]
  58. Pendergast A. M., Quilliam L. A., Cripe L. D., Bassing C. H., Dai Z., Li N., Batzer A., Rabun K. M., Der C. J., Schlessinger J. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell. 1993 Oct 8;75(1):175–185. [PubMed] [Google Scholar]
  59. Pignon J. M., Henni T., Amselem S., Vidaud M., Duquesnoy P., Vernant J. P., Kuentz M., Cordonnier C., Rochant H., Goossens M. Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia. 1990 Feb;4(2):83–86. [PubMed] [Google Scholar]
  60. Preti H. A., O'Brien S., Giralt S., Beran M., Pierce S., Kantarjian H. M. Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients. Am J Med. 1994 Jul;97(1):60–65. doi: 10.1016/0002-9343(94)90049-3. [DOI] [PubMed] [Google Scholar]
  61. Preudhomme C., Vachee A., Lepelley P., Vanrumbeke M., Zandecki M., Quesnel B., Cosson A., Fenaux P. Inactivation of the retinoblastoma gene appears to be very uncommon in myelodysplastic syndromes. Br J Haematol. 1994 May;87(1):61–67. doi: 10.1111/j.1365-2141.1994.tb04871.x. [DOI] [PubMed] [Google Scholar]
  62. Pui C. H., Behm F. G., Downing J. R., Hancock M. L., Shurtleff S. A., Ribeiro R. C., Head D. R., Mahmoud H. H., Sandlund J. T., Furman W. L. 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. J Clin Oncol. 1994 May;12(5):909–915. doi: 10.1200/JCO.1994.12.5.909. [DOI] [PubMed] [Google Scholar]
  63. Raab-Traub N., Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986 Dec 26;47(6):883–889. doi: 10.1016/0092-8674(86)90803-2. [DOI] [PubMed] [Google Scholar]
  64. Raimondi S. C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993 May 1;81(9):2237–2251. [PubMed] [Google Scholar]
  65. Sawyers C. L., McLaughlin J., Goga A., Havlik M., Witte O. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell. 1994 Apr 8;77(1):121–131. doi: 10.1016/0092-8674(94)90240-2. [DOI] [PubMed] [Google Scholar]
  66. Shimamoto Y., Suga K., Shibata K., Matsuzaki M., Yano H., Yamaguchi M. Clinical importance of extraordinary integration patterns of human T-cell lymphotropic virus type I proviral DNA in adult T-cell leukemia/lymphoma. Blood. 1994 Aug 1;84(3):853–858. [PubMed] [Google Scholar]
  67. Shiohara M., el-Deiry W. S., Wada M., Nakamaki T., Takeuchi S., Yang R., Chen D. L., Vogelstein B., Koeffler H. P. Absence of WAF1 mutations in a variety of human malignancies. Blood. 1994 Dec 1;84(11):3781–3784. [PubMed] [Google Scholar]
  68. Sioutos N., Bagg A., Michaud G. Y., Irving S. G., Hartmann D. P., Siragy H., Oliveri D. R., Locker J., Cossman J. Polymerase chain reaction versus Southern blot hybridization. Detection of immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol. 1995 Mar;4(1):8–13. doi: 10.1097/00019606-199503000-00004. [DOI] [PubMed] [Google Scholar]
  69. Tashiro S., Kyo T., Tanaka K., Oguma N., Hashimoto T., Dohy H., Kamada N. The prognostic value of cytogenetic analyses in patients with acute nonlymphocytic leukemia treated with the same intensive chemotherapy. Cancer. 1992 Dec 15;70(12):2809–2815. doi: 10.1002/1097-0142(19921215)70:12<2809::aid-cncr2820701214>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  70. Tien H. F., Wang C. H., Chuang S. M., Chow J. M., Lee F. Y., Liu M. C., Chen Y. C., Shen M. C., Lin D. T., Lin K. H. Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan. Cancer Genet Cytogenet. 1994 May;74(1):40–49. doi: 10.1016/0165-4608(94)90027-2. [DOI] [PubMed] [Google Scholar]
  71. Trümper L. H., Brady G., Bagg A., Gray D., Loke S. L., Griesser H., Wagman R., Braziel R., Gascoyne R. D., Vicini S. Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutations. Blood. 1993 Jun 1;81(11):3097–3115. [PubMed] [Google Scholar]
  72. Wattel E., Preudhomme C., Hecquet B., Vanrumbeke M., Quesnel B., Dervite I., Morel P., Fenaux P. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood. 1994 Nov 1;84(9):3148–3157. [PubMed] [Google Scholar]
  73. Weis K., Rambaud S., Lavau C., Jansen J., Carvalho T., Carmo-Fonseca M., Lamond A., Dejean A. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell. 1994 Jan 28;76(2):345–356. doi: 10.1016/0092-8674(94)90341-7. [DOI] [PubMed] [Google Scholar]
  74. Wiman K. G. The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J. 1993 Jul;7(10):841–845. doi: 10.1096/fasebj.7.10.8393817. [DOI] [PubMed] [Google Scholar]
  75. Yano T., Sander C. A., Clark H. M., Dolezal M. V., Jaffe E. S., Raffeld M. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene. 1993 Oct;8(10):2741–2748. [PubMed] [Google Scholar]
  76. van Dongen J. J., Wolvers-Tettero I. L. Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta. 1991 Apr;198(1-2):93–174. doi: 10.1016/0009-8981(91)90247-a. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES